Changes in patient-reported outcomes during the SENSE Trial: first-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks
Abstract
Publication Date:
2011
Iris type:
1.5 Abstract in rivista
List of contributors:
Alvarez, Cm; Clotet, B; Nelson, M; Uglietti, A; Hill, A; van Delft, Y; Marks, S; Castagna, A.
Published in: